BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 38028973)

  • 1. Bridging the Translational Gap in Heart Failure Research: Using Human iPSC-derived Cardiomyocytes to Accelerate Therapeutic Insights.
    Venegas-Zamora L; Fiedler M; Perez W; Altamirano F
    Methodist Debakey Cardiovasc J; 2023; 19(5):5-15. PubMed ID: 38028973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.
    Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L
    Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of functional cardiomyocytes and cardiac tissue from human induced pluripotent stem cells for regenerative therapy.
    Tani H; Tohyama S; Kishino Y; Kanazawa H; Fukuda K
    J Mol Cell Cardiol; 2022 Mar; 164():83-91. PubMed ID: 34822838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Treatment of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Endothelial Cells Regenerate the Infarcted Heart in Mice and Non-Human Primates.
    Cheng YC; Hsieh ML; Lin CJ; Chang CMC; Huang CY; Puntney R; Wu Moy A; Ting CY; Herr Chan DZ; Nicholson MW; Lin PJ; Chen HC; Kim GC; Zhang J; Coonen J; Basu P; Simmons HA; Liu YW; Hacker TA; Kamp TJ; Hsieh PCH
    Circulation; 2023 Oct; 148(18):1395-1409. PubMed ID: 37732466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of a human iPSC-derived cardiomyocyte/fibroblast engineered heart tissue model.
    Cumberland MJ; Euchner J; Azad AJ; T N Vo N; Kirchhof P; Holmes AP; Denning C; Gehmlich K
    F1000Res; 2023; 12():1224. PubMed ID: 38298530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent immunomodulation and angiogenic effects of mesenchymal stem cells versus cardiomyocytes derived from pluripotent stem cells for treatment of heart failure.
    Liao S; Zhang Y; Ting S; Zhen Z; Luo F; Zhu Z; Jiang Y; Sun S; Lai WH; Lian Q; Tse HF
    Stem Cell Res Ther; 2019 Mar; 10(1):78. PubMed ID: 30845990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-clinical evaluation of the efficacy and safety of human induced pluripotent stem cell-derived cardiomyocyte patch.
    Miyagawa S; Kawamura T; Ito E; Takeda M; Iseoka H; Yokoyama J; Harada A; Mochizuki-Oda N; Imanishi-Ochi Y; Li J; Sasai M; Kitaoka F; Nomura M; Amano N; Takahashi T; Dohi H; Morii E; Sawa Y
    Stem Cell Res Ther; 2024 Mar; 15(1):73. PubMed ID: 38475911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Changes in Morphology and Function of Human Induced Pluripotent Stem Cell Derived Cardiomyocytes (HiPSC-CMs) Cultured on an Aligned-Nanofiber Cardiac Patch.
    Khan M; Xu Y; Hua S; Johnson J; Belevych A; Janssen PM; Gyorke S; Guan J; Angelos MG
    PLoS One; 2015; 10(5):e0126338. PubMed ID: 25993466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid Electrical Stimulation Increased Cardiac Apoptosis Through Disturbance of Calcium Homeostasis and Mitochondrial Dysfunction in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Geng L; Wang Z; Cui C; Zhu Y; Shi J; Wang J; Chen M
    Cell Physiol Biochem; 2018; 47(3):1167-1180. PubMed ID: 29913448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of mitophagy in human iPSC-derived cardiomyocytes.
    Yang M; Fu JD; Zou J; Sridharan D; Zhao MT; Singh H; Krigman J; Khan M; Xin G; Sun N
    Autophagy; 2022 Oct; 18(10):2481-2494. PubMed ID: 35220905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epicardial injection of allogeneic human-induced-pluripotent stem cell-derived cardiomyocytes in patients with advanced heart failure: protocol for a phase I/IIa dose-escalation clinical trial.
    Zhang H; Xue Y; Pan T; Zhu X; Chong H; Xu C; Fan F; Cao H; Zhang B; Pan J; Zhou Q; Yang G; Wang J; Wang DJ
    BMJ Open; 2022 May; 12(5):e056264. PubMed ID: 35523485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of full-length dystrophin impairs normal maturation and contraction of cardiomyocytes derived from human-induced pluripotent stem cells.
    Pioner JM; Guan X; Klaiman JM; Racca AW; Pabon L; Muskheli V; Macadangdang J; Ferrantini C; Hoopmann MR; Moritz RL; Kim DH; Tesi C; Poggesi C; Murry CE; Childers MK; Mack DL; Regnier M
    Cardiovasc Res; 2020 Feb; 116(2):368-382. PubMed ID: 31049579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Approaches in HFpEF: MicroRNAs and iPSC-Derived Cardiomyocytes.
    Kriegel AJ; Gartz M; Afzal MZ; de Lange WJ; Ralphe JC; Strande JL
    J Cardiovasc Transl Res; 2017 Jun; 10(3):295-304. PubMed ID: 28032312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac Toxicity From Ethanol Exposure in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Rampoldi A; Singh M; Wu Q; Duan M; Jha R; Maxwell JT; Bradner JM; Zhang X; Saraf A; Miller GW; Gibson G; Brown LA; Xu C
    Toxicol Sci; 2019 May; 169(1):280-292. PubMed ID: 31059573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene-Edited Human-Induced Pluripotent Stem Cell Lines to Elucidate
    Inácio JM; Nunes MM; Almeida M; Cristo F; Anjos R; Belo JA
    Cells; 2023 Feb; 12(4):. PubMed ID: 36831187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human-induced pluripotent stem cell-derived cardiomyocytes, 3D cardiac structures, and heart-on-a-chip as tools for drug research.
    Andrysiak K; Stępniewski J; Dulak J
    Pflugers Arch; 2021 Jul; 473(7):1061-1085. PubMed ID: 33629131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of two-pore K
    Chai S; Wan X; Nassal DM; Liu H; Moravec CS; Ramirez-Navarro A; Deschênes I
    Am J Physiol Heart Circ Physiol; 2017 Jun; 312(6):H1144-H1153. PubMed ID: 28341634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptome analysis of non human primate-induced pluripotent stem cell-derived cardiomyocytes in 2D monolayer culture vs. 3D engineered heart tissue.
    Yang H; Shao N; Holmström A; Zhao X; Chour T; Chen H; Itzhaki I; Wu H; Ameen M; Cunningham NJ; Tu C; Zhao MT; Tarantal AF; Abilez OJ; Wu JC
    Cardiovasc Res; 2021 Jul; 117(9):2125-2136. PubMed ID: 33002105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Danshen-Enhanced Cardioprotective Effect of Cardioplegia on Ischemia Reperfusion Injury in a Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Model.
    Wei W; Liu Y; Zhang Q; Wang Y; Zhang X; Zhang H
    Artif Organs; 2017 May; 41(5):452-460. PubMed ID: 27925238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Speckle-Tracking Strain Analysis for Mapping Spatiotemporal Contractility of Induced Pluripotent Stem Cell (iPSC)-Derived Cardiomyocytes.
    Izadifar M; Berecz T; Li B; Tang JKKY; Foldes G; Apati A; Nagy A
    Curr Protoc; 2023 Sep; 3(9):e889. PubMed ID: 37747346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.